Fast disintegrating tablets of ondansetron hydrochloride by direct compression technique

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 433-437

  Torne, Sangmesh ^a   Sakarkar, D M ^b   Pawar, S R ^a   Abdul, R ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

^b SN Institute of Pharmacy   (India)

Author keywords

Eudragit EPO; Fast disintegrant tablet; Super disintegrant; Taste masking

Indexed keywords

BUFFER; CROSCARMELLOSE SODIUM; CROSPOVIDONE; EUDRAGIT; ONDANSETRON;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG STABILITY; FAST DISINTEGRATING TABLET; HARDNESS; MASKING; PATIENT COMPLIANCE; PH MEASUREMENT; TABLET COMPRESSION; TABLET FORMULATION; TASTE DISCRIMINATION;

EID: 77953466958     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bandari S., Orodispersible tablets: An overview, Asian J. Pharm., 2008, 2 (1), 2-11.
2. Abdelbary G., Eouani C., Prinderre P., Joachim J., Reyneir J., Determination of the in-vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration, Int. J. Pharm., 2005, 292 (1-2), 29-41.
3. LeBourgeois J.P., Efficacy of an Ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT3 receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis, Clinical oncology, 1999, 11, 340-347.
4. Khan S., Kataria P., Taste masking of Ondansetron Hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets, AAPS PharmSciTech., 2007, 8 (2), E1-E7.
5. Ahmed S.U., Ondansetron orally disintegrating tablets, US Patent No. 7390503, 2008.
6. Adamo F., Fast dispersible/slow releasing Ibuprofen tablets, Eur. J. Pharm. and Biopharm, 2008, 69, 335-341.
7. Sameer G.L., Effects of disintegration-promoting agent lubricants and moisture treatment on optimized fast disintegrating tablets, Int. J. Pharm., 2009, 365, 4-11.
8. Chandrasekhar R., The role of formulation excipients in the development of lyophilized fast-disintegrating tablets, Eur. J. Pharm. and Biopharm, 2009, 1-11.
9. Yara P.A., Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers, Int. J. Pharm., 2009, 366, 149-153.
10. Sradhanjali P., Spectrophotometric method for Ondansetron hydrochloride, Ind. J. Pharm. Sci., 2007, 69 (6), 840-841.
11. Qalaji-Rawas M.M., Simons E.R., Simons K.J., Fast disintegrating sublingual tablets: Effect of Ephinephrine load on tablet characteristic, AAPS PharmSciTech, 2006, 7(2), E1-E7.